SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: dwc who wrote (16569)3/5/1998 4:44:00 PM
From: Henry Niman  Respond to of 32384
 
I know that they will have a booth at the International AIDS Conference in Geneva. I'm not sure about how many different formats they a participating in. Who is sponsoring the forum?



To: dwc who wrote (16569)3/5/1998 5:24:00 PM
From: Henry Niman  Respond to of 32384
 
This was under news:
Thursday March 5, 3:35 pm Eastern Time

Company Press Release

NASDAQ Investor Forum Exhibitor Profile for Ligand Pharmaceuticals

PHOENIX--(BUSINESS WIRE)--March 5, 1998--The following is a profile for Ligand Pharmaceuticals, who will be an
exhibitor at the NASDAQ Investor Forum, March 7, 1998, at the Phoenix Civic Center Plaza.

Company Name: Ligand Pharmaceuticals
Trading Symbol: LGND
Presentation Date/Time: March 7, 1998, 11 a.m. in Seminar Room D
Company Address: 10275 Science Center Drive
City/State/Zip: San Diego, CA 92121
Investor Relations: Susan Atkins
Investor Relations Phone: 619/550-7500
Industry: Pharmaceutical

Presentation Summary:

Ligand Pharmaceuticals develops drugs that regulate hormone activated intracellular receptors. These receptors play a role in
regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers and cardiovascular,
inflammatory and skin diseases.

Contact:

Ligand Pharmaceuticals, San Diego
Susan Atkins, 619/550-7500